(Q53521192)

English

25-Hydroxyvitamin D levels in acute monosymptomatic optic neuritis: relation to clinical severity, paraclinical findings and risk of multiple sclerosis.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25929657

25-Hydroxyvitamin D levels in acute monosymptomatic optic neuritis: relation to clinical severity, paraclinical findings and risk of multiple sclerosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25929657

multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Gorm Pihl-Jensen

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25929657

Jette Lautrup Frederiksen

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25929657

publication date

1 May 2015

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25929657

Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25929657

262

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25929657

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25929657

1646-1654

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25929657

https://scigraph.springernature.com/pub.10.1007/s00415-015-7740-5

0 references

Environmental factors in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Vitamin D in the healthy and inflamed central nervous system: access and function

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

The vitamin D receptor is necessary for 1alpha,25-dihydroxyvitamin D(3) to suppress experimental autoimmune encephalomyelitis in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Optic neuritis, its differential diagnosis and management

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Vitamin D intake and incidence of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Vitamin D as an early predictor of multiple sclerosis activity and progression

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Vitamin D levels and risk of multiple sclerosis in patients with clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Graphical methods for assessing violations of the proportional hazards assumption in Cox regression.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

A Reverse J-Shaped Association of All-Cause Mortality with Serum 25-Hydroxyvitamin D in General Practice: The CopD Study

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

A Reverse J-Shaped Association Between Serum 25-Hydroxyvitamin D and Cardiovascular Disease Mortality: The CopD Study.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7740-5

21 January 2018

Predicting the Outcome of Optic Neuritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25929657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of vitamin D toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/25929657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon Treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/25929657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/25929657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25929657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

25-hydroxyvitamin D Concentrations in Patients with Optic Neuritis as a Clinically Isolated Syndrome and Healthy Controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/25929657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25929657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25929657

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00415-015-7740-5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25929657

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/25929657

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53521192&oldid=1630273902"